Inhibition of receptor-interacting protein 3 upregulation and nuclear translocation involved in Necrostatin-1 protection against hippocampal neuronal programmed necrosis induced by ischemia/reperfusion injury

Brain Res. 2015 Jun 3:1609:63-71. doi: 10.1016/j.brainres.2015.03.024. Epub 2015 Mar 20.

Abstract

Receptor-interacting protein 3 (RIP3) is a key molecular switch in tumor necrosis factor-induced necroptosis requiring the formation of an RIP3-RIP1 complex. We have recently shown that hippocampal cornu ammonis 1 (CA1) neuronal death induced by 20-min global cerebral ischemia/reperfusion (I/R) injury is a form of programmed necrosis. However, the mechanism behind this process is still unclear and was studied here. Global cerebral ischemia was induced by the four-vessel occlusion method and Necrostatin-1 (Nec-1), a specific inhibitor of necroptosis, was administered by intracerebroventricular injection 1h before ischemia. Normally, in the hippocampal CA1 neurons, RIP1 and RIP3 are located in the cytoplasm. However, after I/R injury, RIP3 was upregulated and translocated to the nucleus while RIP1 was not affected. Nec-1 pretreatment prevented hippocampal CA1 neuronal death and I/R induced changes in RIP3. Decreased level of NAD+ in hippocampus and the release of cathepsin-B from lysosomes after I/R injury were also inhibited by Nec-1. Our data demonstrate that Nec-1 inhibits neuronal death by preventing RIP3 upregulation and nuclear translocation, as well as NAD+ depletion and cathepsin-B release. The nuclear translocation of RIP3 has not been reported previously, so this may be an important role for RIP3 during ischemic injury.

Keywords: Global cerebral ischemia; Necrostatin-1; Nuclear translocation; Programmed necrosis; Receptor-interacting protein 3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / metabolism
  • Brain Ischemia / pathology
  • CA1 Region, Hippocampal / drug effects*
  • CA1 Region, Hippocampal / metabolism
  • CA1 Region, Hippocampal / pathology
  • Cathepsin B / metabolism
  • Cell Death / drug effects
  • Cell Death / physiology
  • Cytoplasm / drug effects
  • Cytoplasm / metabolism
  • Dose-Response Relationship, Drug
  • Imidazoles / pharmacology*
  • Indoles / pharmacology*
  • Lysosomes / drug effects
  • Lysosomes / metabolism
  • Lysosomes / pathology
  • Male
  • Necrosis / drug therapy*
  • Necrosis / metabolism
  • Necrosis / pathology
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / pathology
  • Neuroprotective Agents / pharmacology*
  • Poly (ADP-Ribose) Polymerase-1
  • Poly(ADP-ribose) Polymerases / metabolism
  • Protein Serine-Threonine Kinases / metabolism
  • Rats, Sprague-Dawley
  • Receptor-Interacting Protein Serine-Threonine Kinases / metabolism
  • Reperfusion Injury / drug therapy*
  • Reperfusion Injury / metabolism
  • Reperfusion Injury / pathology
  • Up-Regulation / drug effects

Substances

  • Imidazoles
  • Indoles
  • Neuroprotective Agents
  • necrostatin-1
  • Parp1 protein, rat
  • Poly (ADP-Ribose) Polymerase-1
  • Poly(ADP-ribose) Polymerases
  • Protein Serine-Threonine Kinases
  • RIPK1 protein, rat
  • Receptor-Interacting Protein Serine-Threonine Kinases
  • Ripk3 protein, rat
  • Cathepsin B
  • Ctsb protein, rat